About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
LY900014
- Company
- Eli Lilly and Company
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 2 recruiting
Efficacy results: Not yet reported
2 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Oct 1, 2026
Find a Clinical Trial Near Me
See recruiting studies for LY900014 and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT06387199
Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide
Not yet reported, Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 26 participants Est. completion 2027-01 1 site Added to GLP-1Other conditions: Type 1 Diabetes, Diabetes MellitusView official trial listing → -
Recruiting NCT NCT07341373
A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500
Not yet reported Portal Diabetes, Inc. 25 participants Est. completion 2026-09 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT02317575
A Study of LY900014 Formulations in Healthy Participants
Not yet reported Eli Lilly and Company 29 participants Est. completion 2015-09 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT02525744
A Study of a New LY900014 Formulation in Healthy Participants
Not yet reported Eli Lilly and Company 24 participants Est. completion 2015-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02636361
A Study of Various Formulations of LY900014 in Healthy Participants
Not yet reported Eli Lilly and Company 26 participants Est. completion 2016-02 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02703324
A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
Not yet reported Eli Lilly and Company 30 participants Est. completion 2016-08 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT02703337
A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy
Not yet reported Eli Lilly and Company 30 participants Est. completion 2016-08 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02703350
A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy
Not yet reported Eli Lilly and Company 30 participants Est. completion 2016-07 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT02752087
A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants
Not yet reported Eli Lilly and Company 24 participants Est. completion 2016-05 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02770521
A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants
Not yet reported Eli Lilly and Company 23 participants Est. completion 2016-07 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02942654
A Study of LY900014 Formulation in Healthy Participants
Not yet reported Eli Lilly and Company 32 participants Est. completion 2016-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03056456
A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump
Not yet reported Eli Lilly and Company 24 participants Est. completion 2017-06-19 2 sites Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03166124
A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus
Not yet reported Eli Lilly and Company 80 participants Est. completion 2017-11-18 2 sites Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03214367
A Study of LY900014 in Participants With Type 1 Diabetes
Not yet reported Eli Lilly and Company 1392 participants Est. completion 2019-08-22 172 sites Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03214380
A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes
Not yet reported Eli Lilly and Company 933 participants Est. completion 2019-03-13 141 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03232983
A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants
Not yet reported Eli Lilly and Company 28 participants Est. completion 2017-11-09 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03286751
A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants
Not yet reported Eli Lilly and Company 42 participants Est. completion 2018-02-06 2 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03305822
A Study of LY900014 in Participants With Type 2 Diabetes Mellitus
Not yet reported Eli Lilly and Company 38 participants Est. completion 2017-12-14 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03334448
A Study to Compare 2 Formulations of LY900014 in Healthy Participants
Not yet reported Eli Lilly and Company 49 participants Est. completion 2018-03-15 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03341299
A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus
Not yet reported Eli Lilly and Company 36 participants Est. completion 2018-04-03 2 sites Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03341312
A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)
Not yet reported Eli Lilly and Company 36 participants Est. completion 2018-03-31 2 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03407118
A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus
Not yet reported Eli Lilly and Company 31 participants Est. completion 2018-07-12 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03433677
A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes
Not yet reported Eli Lilly and Company 49 participants Est. completion 2018-09-04 5 sites Stand-aloneOther conditions: Diabetes Type 1View official trial listing → -
Completed NCT NCT03449433
A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus
Not yet reported Eli Lilly and Company 80 participants Est. completion 2018-08-14 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03465878
A Study of LY900014 in Participants With Type 1 Diabetes Mellitus
Not yet reported Eli Lilly and Company 56 participants Est. completion 2019-11-14 2 sites Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03616977
Study to Compare 2 Formulations of LY900014 in Healthy Participants
Not yet reported Eli Lilly and Company 69 participants Est. completion 2018-10-19 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03740919
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes
Not yet reported Eli Lilly and Company 751 participants Est. completion 2021-07-02 111 sites Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03760640
A Study of LY900014 in a Medtronic Pump
Not yet reported Eli Lilly and Company 42 participants Est. completion 2019-10-07 2 sites Stand-aloneOther conditions: Type1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03830281
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy
Not yet reported Eli Lilly and Company 471 participants Est. completion 2020-01-06 83 sitesOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03952130
A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes
Not yet reported Eli Lilly and Company 354 participants Est. completion 2022-01-10 30 sites Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03952143
A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes
Not yet reported Eli Lilly and Company 628 participants Est. completion 2021-01-20 41 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04049123
A Study of LY900014 in Healthy Chinese Participants
Not yet reported Eli Lilly and Company 15 participants Est. completion 2020-10-23 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT04276207
A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps
Not yet reported Eli Lilly and Company 32 participants Est. completion 2020-08-10 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT04585776
A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes
Not yet reported Eli Lilly and Company 31 participants Est. completion 2021-05-27 3 sites Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT04605991
A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)
Not yet reported Eli Lilly and Company 187 participants Est. completion 2022-02-04 32 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT05262387
A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes
Not yet reported Eli Lilly and Company 25 participants Est. completion 2023-03-07 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT05325294
Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®
Not yet reported Medtronic MiniMed, Inc. 244 participants Est. completion 2024-01-03 19 sites Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT05403502
Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes
Not yet reported Tandem Diabetes Care, Inc. 183 participants Est. completion 2023-08-02 13 sites Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT05508061
Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes
Not yet reported Inreda Diabetic B.V. 12 participants Est. completion 2023-03-16 3 sites Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Status unknown NCT NCT05660941
Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro (ACOLYTE Study)
Not yet reported Manchester University NHS Foundation Trust 26 participants Est. completion 2024-05-01 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Status unknown NCT NCT06021158
A Trial to Compare Automated Lyumjev Delivery With Carbohydrate Counting, Qualitative Meal-size Estimation, and Meal Detection in Type 1 Diabetes
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 12 participants Est. completion 2024-12 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1, Type 1 DiabetesView official trial listing → -
Status unknown NCT NCT06046417
A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes
Not yet reported, Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 30 participants Est. completion 2025-06 1 site Stand-aloneOther conditions: type1diabetes, Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT06370715
A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India
Not yet reported Eli Lilly and Company 153 participants Est. completion 2025-09-02 12 sites Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT06600776
Mealtime or Post-meal Dosing of URLi in Medtronic 780G Hybrid Closed Loop System
Not yet reported Tel-Aviv Sourasky Medical Center 50 participants Est. completion 2025-10-21 1 siteOther conditions: Type 1 Diabetes (T1D)View official trial listing → -
Suspended NCT NCT06854861
Premixed Glucagon/Insulin Solution for Faster Insulin Absorption in Type 1 Diabetes
Not yet reported, Not yet reported St. Olavs Hospital 30 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT06948760
Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D
Not yet reported Mark D. DeBoer, MD, MSc., MCR 11 participants Est. completion 2026-03-10 1 site Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT07090824
Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes
Not yet reported Stanford University 10 participants Est. completion 2026-05-29 1 siteOther conditions: Diabetes Mellitus, Type 1, Type 1 Diabetes MellitusView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: LY900014, Insulin Lispro-aabc, Lyumjev
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.